|
ANEB Anebulo Pharmaceuticals Inc 1815974 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-1,999,397.00 |
| Balance Sheet |
|
Current Assets
|
$9,273,766.00 |
|
Assets
|
$9,421,997.00 |
|
Liabilities
|
$1,485,646.00 |
|
Equity
|
$7,936,351.00 |
|
Shares Out
|
41084731.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,586,279.00 |
| Market Analysis |
Market Cap
|
$10,682,030.06 |
|
Price
|
$0.28 |
|
BVPS
|
0.19 |
|
PB
|
1.37 |
|
EPS
|
-0.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:32:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANEB documents filed with the SEC.
ANEB Filings
Clear
